Merck faces ongoing claims after Texan ruling on rofecoxib.
Tanne
Janice Hopkins
JH
D016861:Cyclooxygenase Inhibitors; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D007783:Lactones; D016365:Liability, Legal; D013450:Sulfones; D013781:Texas
D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib